• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Astera Labs Appoints Dr. Craig Barratt to Board of Directors

    3/3/25 4:05:00 PM ET
    $ALAB
    $ISRG
    Semiconductors
    Technology
    Industrial Specialties
    Health Care
    Get the next $ALAB alert in real time by email

    SANTA CLARA, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- Astera Labs, Inc. (NASDAQ:ALAB), a global leader in semiconductor-based connectivity solutions for AI and cloud infrastructure, today announced the appointment of Dr. Craig Barratt to its Board of Directors. Dr. Barratt is a seasoned technology industry veteran with decades of experience as an impactful leader and board member at networking, semiconductor, and medical device companies.

    "Craig's proven track record of scaling high-growth technology companies and driving breakthrough innovations at industry leaders like Atheros, Google, and Qualcomm makes him an invaluable addition to Astera Labs' Board of Directors," said Jitendra Mohan, CEO and Co-founder, Astera Labs. "His strategic insight and deep technical expertise will provide critical guidance as we continue to expand our leadership in connectivity solutions for AI and cloud infrastructure."

    Dr. Barratt served as President, CEO, and a Director of Atheros Communications, Inc., a fabless semiconductor company and Silicon Valley success story that developed wireless and wired communication technologies. During his tenure, he led the company through an IPO until its acquisition by Qualcomm, when he then took up the position of President at Qualcomm Atheros, the networking and connectivity subsidiary of Qualcomm.

    Dr. Barratt is also the former Senior Vice President and General Manager of the Connectivity Group at Intel Corporation, since its acquisition of Barefoot Networks, Inc., where he led the computer networking company as President and CEO. Prior to Barefoot Networks, he held several roles at Google, Inc., including Senior Vice President, Access and Energy.

    Dr. Barratt currently chairs the board of Intuitive Surgical, Inc. (NASDAQ:ISRG) – a medical device technology market leader – and previously served on the board of IonQ Inc. He holds doctorate and Master of Science degrees in electrical engineering from Stanford University, as well as undergraduate degrees in electrical engineering and in pure mathematics and physics from the University of Sydney.

    "Craig is a highly accomplished leader with deep expertise in scaling innovative technology companies and shaping transformative products in the semiconductor and networking industries," said Manuel Alba, Chairman of the Board, Astera Labs. "His extensive board and executive experience, combined with his strategic vision, will be instrumental in helping to steer Astera Labs as we continue our rapid growth and innovation in AI connectivity."

    "Astera Labs is at the forefront of enabling the next generation of AI and cloud infrastructure with its unmatched execution in addressing the industry's most critical connectivity bottlenecks," said Dr. Craig Barratt. "I am excited to join the Board and collaborate with the team to support the company's strong momentum and strengthen its industry leadership."

    About Astera Labs

    Astera Labs is a global leader in purpose-built connectivity solutions that unlock the full potential of AI and cloud infrastructure. Our Intelligent Connectivity Platform integrates PCIe®, CXL®, and Ethernet semiconductor-based solutions and the COSMOS software suite of system management and optimization tools to deliver a software-defined architecture that is both scalable and customizable. Inspired by trusted relationships with hyperscalers and the data center ecosystem, we are an innovation leader delivering products that are flexible and interoperable. Discover how we are transforming modern data-driven applications at www.asteralabs.com.

    © Astera Labs, Inc. Astera Labs, and its stylized logo, are trademarks of Astera Labs, Inc. or its affiliates. Other names and brands may be claimed as the property of others.

    CONTACT: Joe Balich

    [email protected]

    INVESTOR CONTACT: Leslie Green

    [email protected]



    Primary Logo

    Get the next $ALAB alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALAB
    $ISRG

    CompanyDatePrice TargetRatingAnalyst
    Intuitive Surgical Inc.
    $ISRG
    1/27/2026$660.00Buy
    TD Cowen
    Astera Labs Inc.
    $ALAB
    1/15/2026Outperform
    RBC Capital Mkts
    Intuitive Surgical Inc.
    $ISRG
    12/11/2025$635.00Buy → Neutral
    Citigroup
    Astera Labs Inc.
    $ALAB
    11/21/2025Mkt Perform
    Raymond James
    Astera Labs Inc.
    $ALAB
    11/20/2025$225.00Outperform
    BNP Paribas Exane
    Astera Labs Inc.
    $ALAB
    11/17/2025Market Perform → Outperform
    Northland Capital
    Astera Labs Inc.
    $ALAB
    11/5/2025$205.00 → $220.00Buy
    Needham
    Astera Labs Inc.
    $ALAB
    11/5/2025$185.00 → $200.00Buy
    Stifel
    More analyst ratings

    $ALAB
    $ISRG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    TD Cowen initiated coverage on Intuitive Surgical with a new price target

    TD Cowen initiated coverage of Intuitive Surgical with a rating of Buy and set a new price target of $660.00

    1/27/26 8:46:58 AM ET
    $ISRG
    Industrial Specialties
    Health Care

    RBC Capital Mkts initiated coverage on Astera Labs

    RBC Capital Mkts initiated coverage of Astera Labs with a rating of Outperform

    1/15/26 8:34:58 AM ET
    $ALAB
    Semiconductors
    Technology

    Intuitive Surgical downgraded by Citigroup with a new price target

    Citigroup downgraded Intuitive Surgical from Buy to Neutral and set a new price target of $635.00

    12/11/25 8:53:00 AM ET
    $ISRG
    Industrial Specialties
    Health Care

    $ALAB
    $ISRG
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Da Vinci 5 Cleared for Cardiac Procedures

    SUNNYVALE, Calif., Jan. 26, 2026 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced that the U.S. Food and Drug Administration (FDA) has cleared the da Vinci 5 system for certain cardiac procedures, including mitral valve repair and IMA (internal mammary artery) mobilization for cardiac revascularization.         Cardiovascular disease remains the leading cause of death worldwide, claiming nearly 18 million lives each year.i More than two million patients worldwide undergo open heart surgery annuallyii, with most procedures requiring a sternotomy, an approach that involves splitting

    1/26/26 9:15:00 AM ET
    $ISRG
    Industrial Specialties
    Health Care

    20 Million Patients Benefit from da Vinci Surgery Globally

    SUNNYVALE, Calif., Jan. 23, 2026 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced that more than 20 million patients worldwide have been operated on by surgeons using da Vinci surgical systems. The milestone was reached as of the end of 2025, with more than 3.1 million da Vinci procedures performed last year alone. This achievement reflects the continued adoption of, and expanded patient access to, Intuitive's minimally invasive technology. "This achievement is a direct result of the dedication of surgeons and care teams around the globe to provide the best possible care for their pat

    1/23/26 9:15:00 AM ET
    $ISRG
    Industrial Specialties
    Health Care

    UPDATE -- Astera Labs Broadens Scorpio X-Series Smart Fabric Switch Roadmap to Address Expanding Scale-Up Market Opportunities

    Scorpio X-Series Begins Initial Production with Merchant Scale-Up Switching Market Estimated to Reach $20 billion by 20301 News Highlights: Developed in collaboration with hyperscalers, Scorpio X-series products are purpose-built to support scale-up networking, and are now shipping in initial production volumesExpanded features will include support for increased radix, platform-specific protocols, in-network computing, Hypercast technology, and optical connectivity SAN JOSE, Calif., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Astera Labs, Inc. (NASDAQ:ALAB), a leader in semiconductor-based connectivity solutions for rack-scale AI infrastructure, today announced an expanded portfolio roadmap that

    1/22/26 6:13:27 PM ET
    $ALAB
    Semiconductors
    Technology

    $ALAB
    $ISRG
    SEC Filings

    View All

    Intuitive Surgical Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - INTUITIVE SURGICAL INC (0001035267) (Filer)

    1/22/26 4:05:12 PM ET
    $ISRG
    Industrial Specialties
    Health Care

    Astera Labs Inc. filed SEC Form 8-K: Leadership Update

    8-K - Astera Labs, Inc. (0001736297) (Filer)

    1/20/26 4:01:34 PM ET
    $ALAB
    Semiconductors
    Technology

    Intuitive Surgical Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - INTUITIVE SURGICAL INC (0001035267) (Filer)

    1/14/26 8:58:49 AM ET
    $ISRG
    Industrial Specialties
    Health Care

    $ALAB
    $ISRG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Leonard Keith R disposed of 369 shares, decreasing direct ownership by 50% to 370 units (SEC Form 4)

    4 - INTUITIVE SURGICAL INC (0001035267) (Issuer)

    1/30/26 9:45:03 PM ET
    $ISRG
    Industrial Specialties
    Health Care

    SEC Form 4 filed by SVP & Chief Mfg and Supply Cha Brosius Mark

    4 - INTUITIVE SURGICAL INC (0001035267) (Issuer)

    1/30/26 9:28:38 PM ET
    $ISRG
    Industrial Specialties
    Health Care

    SEC Form 4 filed by EVP & Chief Legal and Complian Loeb Gary

    4 - INTUITIVE SURGICAL INC (0001035267) (Issuer)

    1/30/26 9:24:32 PM ET
    $ISRG
    Industrial Specialties
    Health Care

    $ALAB
    $ISRG
    Leadership Updates

    Live Leadership Updates

    View All

    Intel Appoints Dr. Craig H. Barratt to Board of Directors

    Intel Corporation (NASDAQ:INTC) today announced that Craig H. Barratt, Ph.D., 63, has been appointed to its board of directors, effective immediately. Dr. Barratt will serve as an independent director. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251110908011/en/Dr. Craig H. Barratt joins Intel's board as an independent director. "Craig is a highly accomplished technology leader with a proven ability to innovate, scale, and transform businesses," said Lip-Bu Tan, Intel CEO. "He is a seasoned semiconductor executive with experience at multiple leading-edge technology companies, which will be invaluable as we continue to execute

    11/10/25 6:21:00 PM ET
    $ALAB
    $INTC
    $ISRG
    Semiconductors
    Technology
    Industrial Specialties
    Health Care

    30 years of Innovation and Impact: Dan Larson's Inspiring Story

    SUNNYVALE, Calif., May 27, 2025 (GLOBE NEWSWIRE) -- When Seattle resident Dan Larson was diagnosed with lung cancer in 2023, his only exposure to robotic technology was through his work as a quality engineer at Boeing. He could never have imagined that robotic technology made by Intuitive, the pioneer of robotic-assisted surgery, would one day play a pivotal role in his health care. Having experienced the loss of his father to lung cancer, Dan was determined to overcome his own diagnosis and enjoy his retirement with his family. Under the care of clinicians at MultiCare Tacoma General Hospital in Washington, Dan underwent two robotic lung biopsies with the Ion Endoluminal System, Intuit

    5/27/25 9:15:00 AM ET
    $ISRG
    Industrial Specialties
    Health Care

    Intuitive Announces CEO Transition Effective July 1, 2025

    President Dave Rosa promoted to CEOCurrent CEO Gary Guthart to become executive chair of Intuitive's boardCurrent Board Chair Craig Barratt to become lead independent director SUNNYVALE, Calif., May 15, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced the promotion of President Dave Rosa to chief executive officer, effective July 1, 2025. At that time, current CEO Gary Guthart will become the executive chair of Intuitive's board of directors, and current Board Chair Craig Barratt will become lead independent director. Guthart will work closely with Rosa to support a smooth t

    5/15/25 9:05:00 AM ET
    $ISRG
    Industrial Specialties
    Health Care

    $ALAB
    $ISRG
    Financials

    Live finance-specific insights

    View All

    Intuitive Announces Fourth Quarter Earnings

    SUNNYVALE, Calif., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Intuitive (the "Company") (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended December 31, 2025. Q4 Highlights Worldwide procedures (da Vinci and Ion combined) grew approximately 18% compared with the fourth quarter of 2024. Da Vinci procedures grew approximately 17% and Ion procedures grew approximately 44%.The Company placed 532 da Vinci surgical systems, compared with 493 in the fourth quarter of 2024. The fourth quarter 2025 da Vinci surgical system placements included 303 da Vinci 5 systems, compared with 174 i

    1/22/26 4:05:00 PM ET
    $ISRG
    Industrial Specialties
    Health Care

    Intuitive Announces Preliminary Fourth Quarter and Full Year 2025 Results

    SUNNYVALE, Calif., Jan. 14, 2026 (GLOBE NEWSWIRE) -- Intuitive (the "Company") (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced certain unaudited preliminary fourth quarter and full year 2025 financial results ahead of its presentation at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026. Financial and Operational Highlights Fourth quarter 2025 worldwide procedures (da Vinci and Ion combined) grew approximately 18% compared with the fourth quarter of 2024. Da Vinci procedures grew approximately 17% and Ion procedures grew approximately 44%. Average da Vinci system utilization increased 4%

    1/14/26 9:05:00 AM ET
    $ISRG
    Industrial Specialties
    Health Care

    Astera Labs Announces Conference Call to Review Fourth Quarter 2025 Financial Results

    SANTA CLARA, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Astera Labs, Inc. (NASDAQ:ALAB), a leader in semiconductor-based connectivity solutions for rack-scale AI infrastructure, today announced that it will release its financial results for the fourth quarter 2025 after the close of market on Tuesday, Feb. 10, 2026. Astera Labs will host a corresponding conference call at 1:30 p.m. Pacific Time, 4:30 p.m. Eastern Time. Conference Call Details Date: Feb. 10, 2026Time: 1:30 pm PT / 4:30 pm ET Hosts:Jitendra Mohan, Chief Executive Officer Sanjay Gajendra, President and Chief Operating Officer Mike Tate, Chief Financial OfficerDial-in:(800) 715-9871 Conference ID: 5908687Webcast:https://ir.ast

    1/8/26 4:05:00 PM ET
    $ALAB
    Semiconductors
    Technology

    $ALAB
    $ISRG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Astera Labs Inc.

    SC 13G - Astera Labs, Inc. (0001736297) (Subject)

    11/19/24 5:17:17 PM ET
    $ALAB
    Semiconductors
    Technology

    SEC Form SC 13G filed by Astera Labs Inc.

    SC 13G - Astera Labs, Inc. (0001736297) (Subject)

    11/19/24 5:10:50 PM ET
    $ALAB
    Semiconductors
    Technology

    SEC Form SC 13G filed by Astera Labs Inc.

    SC 13G - Astera Labs, Inc. (0001736297) (Subject)

    11/14/24 4:11:12 PM ET
    $ALAB
    Semiconductors
    Technology